Cardio: Adrenergic / Cholinergics Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

ALPHA 1 RECEPTOR

Tissues - Actions (3)

A

“Gimme an alpha 1 VID

(1) Most Vascular smooth muscle- contracts (inc. vascular resistance)
(2) Dilator Pupillary muscle- contracts (myDriasis)
(3) Internal Urethral Sphincter- contracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ALPHA 2 RECEPTOR

Tissues- Actions (4)

A

“You’ll find alpha 2 receptors on a PEAA

(1) A**drenergic and cholinergic nerve terminals- inhibits NTS release–> [CNS-mediated BP DEC]
(2) *Platelets
- stimulates aggregation
(3) *Adipocytes
- DEC Lipolysis
(4) Eye - DEC Intraocular pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BETA 1 RECEPTOR

Actions (2)

A

(1) Heart- INC rate and force by [INC [Na+ I(f) channels] in phase 0 of AV node] –> shortens PR interval
(2) JGA cells- Stimulates renin release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

BETA 2 RECEPTOR

Tissues-Actions (4)

A

(1) Relaxes RUV - (Respiratory, Uterine and Vascular) smooth muscle
(2) Liver- stimulates glycogenolysis
(3) Pancreatic B cells- stimulates insulin release
(4) Somatic motor nerve terminals (voluntary muscle)- causes tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BETA 3 RECEPTOR Tissues-Actions

A

(B1 and B2 may also contribute)(1) Fat cells- stimulates lipolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DOPAMINE 1 RECEPTOR

Tissues-Actions

A

Renal and other splanchnic blood vessels- vasoDilates (reduces resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DOPAMINE 2 RECEPTORTissues-Actions

A

(1) Nerve terminals- inhibits adenylyl cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Timolol:Half-Life

A

4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Timolol:Mechanism of Action

A

General B-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Timolol:Indication

A

Glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nadolol:Half-Life

A

20-24 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nadolol:Mechanism of Action

A

General B-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nadolol:Indication (2)

A

Long term angina, hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atenolol

MOA

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Atenolol:Indication (3)

A

Hypertension, angina, MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Metoprolol:Mechanism of Action

A

B1-antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Metoprolol:Indication (2)

A

Hypertension, long-term angina rx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pindolol:A: Mechanism of ActionB: Because of its MOA, it has less _______ effect on the heart.

A

A: B-antagonist with partial agonist activity at both B1 and B2 adrenergic R B: Since some B signal remains (partial agonist), partial agonist have less BRADYCARDIC effect, thus should be used when patients are less tolerant to bradycardic effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pindolol:A: IndicationB: Therapeutic benefit is good when (indication) is due to _________.

A

A: HypertensionB: Therapeutic benefit is good when HTN is due to HIGH SYMPATHETIC OUTPUT since blockade of endogenous agonist will predominate over partial agonist effect of drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Esmolol:Half-life

A

~9 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Esmolol:Mechanism of Action

A

B1-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Esmolol:A: Indication (3) B: Esmolol has a very ____ half life, so it is given ____(dosage form) in _______ crisis, _____ angina and _______

A

Esmolol: A: Indication: -HTN Crisis-Angina (unstable) -Supraventricular tachycardiaB: Esmolol has a very SHORT half life (9 min), so it is given IV in hypertensive crisis, unstable angina, SVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Phenoxybenzamine:

Mechanism of Action

A

Irreversible [General alpha-blocker]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Phenoxybenzamine:

Indication

A

Pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Phentolamine:

Mechanism of Action

A

General alpha-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Phentolamine

Indication (3)

A

Catecholamine-induced HTN Crisis

  1. rx for pheochromocytoma before surgery
  2. MAOI Crisis
  3. Cocaine OD

IS REVERSIBLE!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Prazosin:

Mechanism of Action

A

[Alpha 1 BLOCKER]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the three cardioselective B1-blockers?

A

Metoprolol, Atenolol, Esmolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the cardiovascular effects of the cardioselective B1-blockers….-HR/Contractility? -Renin Release? -Vasoregulation?

A

Reduced heart rate and contractility, reduced renin release, reduced vasoconstriction (due to the reduced angio II)[same as non-selective B blockers]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Cardioselective B1 BLOCKERS:Therapeutic use (3)

A

Hypertension, angina, arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Cardioselective B1-blockers:Toxicity (4)

A

Depression, insomnia, hypotension, bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Cardioselective B1-blockers:Contraindications (2)

A
  • Pt with 2nd/3rd degree heart block -Pt with cardiogenic shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

EPINEPHRINE Half-Life

A

Short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

EPINEPHRINE

MOA (2)

A

[General ALPHA agonist{HIGH CONCENTRATION}

and

[General Beta agonist{low concentration}]

“with low effort you’ll get a B….with HIGH EFFORT YOU’LL GET AN A”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

EPINEPHRINE ELIMINATION

A

COMT —> Urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

EPINEPHRINE INDICATION (4)

A

EPINEPHRINE Indication: •Anaphylaxis •Shock•Cardiac Arrest•Heart Block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

EPINEPHRINE TOXICITY

A

Arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

NorEpi

MOA (2)

A

[General alpha agonist] + [Beta 1 agonist]

a1 > a2 > B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

NorEpiElimination

A

MOA and COMT—> urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

NorEpiIndication

A

Acute hypOtension due to VASODILATORY shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

DOPAMINEHALF-LIFE

A

2-3 MIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

DOPAMINE

MOA (2)

A

[General Beta Agonist] + [SOME alpha agonist activity]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

DOPAMINEELIMINATION

A

MOA AND COMT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

DOPAMINEINDICATION

A

Cardiogenic Shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

IsoProterenolHalf-life

A

short

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

IsoProterenol

MOA

A

[General Beta Agonist]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

IsoProterenolElimination

A

COMT —> Urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

IsoProterenolINDICATIONS (2)

A

IsoProterenol1) Transient Heart Block2) Bronchospasm during Anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

DoButamineHALF-LIFE

A

2-3 MIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

DoButamine

MOA

A

[MOSTLY Beta 1 AGONIST] ; some beta 2 activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

DoButamineELIMINATION

A

COMT—> Urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

DoButamineINDICATION

A

Short term for INC cardiac contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

DoButamineTOXICITY

A

Hypotension (from vasoDilation;Beta 2 activity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

IsoProterenol TOXICITY

A

Tachyarrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

DOPAMINEToxicity (2)

A

-Low BP-Ischemia

56
Q

NorEpi

TOXICITY (2)

A
  • Ischemia
  • NE Extravasation (IV) –> Use [PhenTolamine as antidote]
57
Q

EPININEPHRINETOXICITY

A

ARRHYTHMIAS

58
Q

NorEPINEPHRINE -CO? -TPR? -HR? -OVERALL MAP?

A

NorEPINEPHRINE Physiological effects: ºIncreased CO; ºincrease TPR; ºdecrease HR (baroreflex); ºoverall increased MAP

59
Q

DOPAMINE

A: LOW DOSE: _____ TPR/ _______ CO;

vs.

HIGH DOSE: ______ TPR and _____ MAP

A

LOW DOSE: decreased TPR/ increased CO;

vs.

HIGH DOSE: Increased MAP and TPR

60
Q

IsoProterenol Physiological effects-TPR? -CO? -MAP? -Broncho____(constricts/dilates)

A

IsoProterenol Physiological effects: Decreased TPR; Increased CO; Small decrease in MAP; bronchodilation

61
Q

DOBUTAMINE Physiological effects-CO? -inotropic vs. chronotropic?

A

DOBUTAMINE Physiological effects: Increased CO-MORE INOTROPIC due to [LOW INVOLVEMENT OF baroreceptor reflex which would normally INC chronotropic effects from compensation to hypOtension]`

62
Q

TERBUTALINE Physiological effects-Broncho____(constricts/dilates)-Uterine contraction vs. relaxation?

A

TERBUTALINE Physiological effects: Bronchodilation; Uterine relaxation

63
Q

TERBUTALINEToxicity (3)

A

TERBUTALINEToxicity: Tachycardia; Muscle tremor; Tolerance

64
Q

TERBUTALINEMOA

A

TERBUTALINE[BETA TWO AGONIST]

65
Q

TERBUTALINEINDICATIONS

A

TERBUTALINEPrevent and Reverse Bronchospasm in [Asthma/Bronchitis/Emphysema] Pts

66
Q

ALBUTEROLMOA

A

[BETA TWO AGONIST]

67
Q

ALBUTEROLINDICATION

A

Bronchial Smooth Muscle Relaxation

68
Q

PHENYLEPHRINE

Physiological effects:

-TPR? -MAP? -HR? -PUPIL? -BRONCHIOLE SECRETION?

A

PHENYLEPHRINE Physiological effects:

  • Increased TPR and MAP;
  • decreased HR (baroreflex);
  • Pupillary dilation;
  • decrease bronchiole and sinus secretions.
69
Q

PHENYLEPHRINE

HALF-LIFE

A

metabolizes slowly (less than 1 hour) because it is NOT degraded by [Plasma COMT]

70
Q

PHENYLEPHRINE

Mechanism of Action

A

[alpha 1 AGONIST]

71
Q

PHENYLEPHRINEELIMINATION

A

MAO

72
Q

PHENYLEPHRINE

Indication (4)

A
  • PRESSOR during Anesthesia
  • Nasal Congestion
  • Dilate Pupils for Eye Exam (mydriatic agent)
  • SVT
73
Q

PHENYLEPHRINE:Can Cause ____[INC/DEC] in HR due to _____ ______

A

PHENYLEPHRINE: Can cause DEC in HR due to [Baroreceptor Reflex] when peripheral vasoconstriction is initiated

74
Q

CLONIDINEMOA

A

[alpha TWO AGONIST]

75
Q

CLONIDINEELIMINATION

A

Urinated Out

76
Q

CLONIDINEINDICATION (2)

A

•HTN•Analgesia

77
Q

CLONIDINETOXICITY

A

CLONIDINE Toxicity: (x) Dry Mouth(x) HTN Crisis if withdrawn after Chronic Usage

78
Q

CLONIDINEWorks by _____[INC/DEC] Peripheral vasoconstriction CENTRALLY but will have some _____[INC/DEC] Peripheral vasoconstriction by acting directly in the ______

A

CLONIDINE Works by DECREASING Peripheral vasoconstriction CENTRALLY (inhibits sympathetics) but will have SOME INC peripheral vasoconstriction by acting directly in the PERIPHERY/ BODY

79
Q

AMPHETAMINEPhysiological effects:-TPR?-Inotropic vs. Chronotropic? -MAP?

A

AMPHETAMINE Physiological effects: ºIncreased TPR/diastolic BP ºPositive inotropic and Positive chronotropic effects; º increased MAP pressure

80
Q

AMPHETAMINEMOA

A

AMPHETAMINE MOA: [Indirect sympathoMimetic] - Causes NorEpi Release

81
Q

AMPHETAMINEINDICATION (3)

A

ADHD / narcolepsy / [nasal congestion]

82
Q

AMPHETAMINE Toxicity (4)

A

AMPHETAMINE Toxicity: (x) Tachycardia(x) HTN(x) Anxiety(x) tyramine accumulation if patient has taken MAO inhibitor within the previous 2 weeks is why MAO inhibitors are CONTRAINDICATED w/Amphetamine ———————————————————————————-“T.H.A.t Amphetamine is TOXIC”

83
Q

AMPHETAMINE is an _______ Agent

A

AMPHETAMINE is an Anorexic Agent

84
Q

PARTIAL BETA AGONISTExamples (1)

A

-Pindolol

85
Q

PARTIAL BETA AGONISTMechanism: Treats HTN effectively when HTN is secondary to________. [Partial Beta Agonist] work by reducing _______ binding. They will still INC HR/Contractility BUT NOT AS MUCH AS _______ and since it prevents _______, the baseline HR/Contractility actually goes down from where it was initially **Is used for pts who can’t tolerate _______ very well with traditional [_______ _______ blockers]

A

PARTIAL BETA RECEPTOR AGONISTMechanism: Treats HTN effectively when HTN is secondary to [HIGH Sympathetics]. [Partial Beta Agonist] work by reducing [NOrEPI/EPI] binding. Pindolol will still INC HR/Contractility BUT NOT AS MUCH AS NOrEPI/EPI and since it prevents NOREPI/EPI, the baseline HR/Contractility actually goes down from where it was initially **Is used for pts who can’t tolerate bradycardia very well with traditional [Cardioselective beta blockers]

86
Q

PARTIAL BETA AGONIST-HR? -Heart Contractility? -Renin Release?

A

PARTIAL BETA RECEPTOR AGONISTCV Effects (These CV Effects are most manifested when Sympathetics is the original cause) *DEC HR*DEC Heart Contractility*DEC Renin Release

87
Q

PARTIAL BETA RECEPTOR AGONISTUSES (1)

A

HTN (for pt less tolerant to bradycardia/reduced exercise capacity)

88
Q

PARTIAL BETA RECEPTOR AGONISTTOXICITY (5)

A

Toxicity are the same as the [NON-SELECTIVE BETA BLOCKERS] (1) Bronchospasm(2) mask symptoms of hypoglycemia(3) CNS effects including insomnia and depression(4) can raise triglycerides(5) bradycardia

89
Q

PARTIAL BETA RECEPTOR AGONISTContraindications (2)

A

*2nd/3rd Degree heart Block*Cardiogenic Shock

90
Q

ALPHA ADRENERGIC RECEPTOR BLOCKEREXAMPLES (2)

A

ALPHA ADRENERGIC RECEPTOR BLOCKER*[iRReversible Phenoxybenazmine] *[REVERSIBLE PHENTOLAMINE]

91
Q

ALPHA ADRENERGIC RECEPTOR BLOCKERCV Effects (3)

A

ALPHA ADRENERGIC RECEPTOR BLOCKER1. Prevents vasoconstriction–> DEC BP—>but will cause reflex INC in NorEpi release 2. INC inotropy and INC Chronotropy due to blocking the [a2 pre-synaptic receptor] –> Release of NorEpi @ nerve terminals3. will unmasks vasodilatory effect of Epi

92
Q

ALPHA ADRENERGIC RECEPTOR BLOCKERUSES (2)

A

*perioperative tx of pheochromocytoma *Dermal Necrosis

93
Q

GENERAL ALPHA BLOCKERTOXICITY (3)

A

GENERAL ALPHA BLOCKERToxicity: (x) Prolonged hypOtension(x) Reflex Tachycardia (x) Nasal Congestion “It’s TOXIC to give ur pt [General Alpha Blocker’s] PRN”

94
Q

ALPHA ADRENERGIC RECEPTOR BLOCKERContraindications (1)

A

ALPHA ADRENERGIC RECEPTOR BLOCKERContraindications: Pt with Coronary Artery Dz

95
Q

ALPHA 1 BLOCKER

EXAMPLES (3)

A

ALPHA 1 RECEPTOR BLOCKER

Examples: -Prazosin /Doxazosin /Terazosin

96
Q

ALPHA 1 RECEPTOR BLOCKER

CV Effects (2)

*Prevents _______*[Less HR INC / Contractility INC] than [NON-selctive alpha receptor blockers] because ____________. This ultimately DEC _______ release in the synaptic cleft and SA Node is not stimulated any further

A

ALPHA 1 RECEPTOR BLOCKER

CV Effects:

*Prevents Vasoconstriction*[Less HR INC / Contractility INC] than [NON-selctive alpha receptor blockers] since [alpha 2 receptor] on [pre-synpatic nerve terminal] IS STILL FUNCTIONAL and can still negatively feedback when NorEpi is released—> ultimately DEC NorEpi release in the synaptic cleft and SA Node is not stimulated no further

97
Q

ALPHA 1 RECEPTOR BLOCKER

Indications (2)

A

ALPHA 1 RECEPTOR BLOCKER

ºHTN

ºBenign Prostatic Hyperplasia

98
Q

ALPHA 1 RECEPTOR BLOCKERTOXICITY (2)

A

ALPHA 1 RECEPTOR BLOCKER TOXICITY: (x) Syncope (x) Orthostatic hypOtension

99
Q

Methylphenidate:MOA

A

Indirect sympathomimetic (increases NE and dopamine)

100
Q

Methylphenidate:Indication

A

ADHD

101
Q

Ephedrine:MOA

A

Indirect sympathomimetic

102
Q

Ephedrine:Indication

A

Pressor agent with anesthesia

103
Q

What main drugs make up the Amphetamine family ? (6)

A
  1. Amphetamine2. Methamphetamine3. Methylphenidate4. Ephedrine5. Pseudoephedrine 6. Tyramine
104
Q

Pseudo-ephedrine:MOA

A

Indirect sympathomimetic

105
Q

Pseudo-ephedrine:Indication

A

Nasal decongestion

106
Q

Tyramine:MOA

A

Displaces NE

107
Q

Tyramine:Half-life

A

Normally very short

108
Q

Tyramine:Indications

A

Not therapeutic

109
Q

Tyramine:Elimination

A

MAO

110
Q

Propanolol:MOA

A

General (non-selective) Beta Blocker

111
Q

Propanolol:Indications (3)

A
  1. Hypertension2. Angina due to atherosclerosis3. MI
112
Q

Timolol:MOA

A

General (non-selective) Beta Blocker

113
Q

Timolol: Indications

A

Glaucoma

114
Q

Nadolol:Half-life

A

20-24 hrs

115
Q

Nadolol:MOA

A

General (non-selective) Beta-blocker

116
Q

Nadolol:Indications (2)

A
  1. Long-term angina2. Hypertension
117
Q

What are the Non-selective Beta-blockers? (3)

A

Propanolol, nadolol, timolol

118
Q

Cardiovascular effects of Non-selective Beta-blockers? (3)

A
  1. Reduced heart rate2. Reduced contractility3. Reduced vasoconstriction (as a result of reduced RENIN release)
119
Q

Effect of Non-selective Beta-blockers on bronchioles? (1)

A

Can cause bronchiole constriction in those with asthma or COPD.

120
Q

Non-selective Beta-blockers:Toxicity (5)

A
  1. Bronchospasm2. Bradycardia3. CNS effects (insomnia/depression)4. MASK sx of hypOglycemia 5. Triglyceride INC———————————————————————————-“(General) B Blockers Can Modulate Triglycerides “
121
Q

Non-selective Beta-blockers:Contraindications (4)

A
  1. Heart Block2. Sinus bradycardia3. Bronchial Asthma4. Cardiogenic shock”[He Should Be Careful] w/General Beta Blockers”
122
Q

LIST THE 5 Drugs Eliminated by COMT

A

“COMT d.i.N.e.D on 5 Drugs”1. doButamine2. isoProterenol 3. NOREPI [MAO and COMT]4 epi5. DOPAMINE [MAO and COMT]

123
Q

Name the 4 Medications that Prevent LV Remodeling in HF pts

A

BANA helps HF pts live Loonger”

  1. Beta Blockers (Metoprolol / Carvedilol)
  2. [ACEk2 inhibitors AND ARBs]
  3. Aldosterone Blockers (Spironolactone / Eplerenone)
  4. [Nitrates + Hydralazine]
124
Q

A: Tx for [Stable Angina]

B: MOA

A

A: Sublingual NTG

B: Systemic VasoDilation (venodilation) –> [DEC LV Preload] —> [DEC myocardial O2 demand]

125
Q

Bethanechol MOA

A

Muscarinic Cholinergic Agonist

126
Q

A: Bethanechol Indication (2)

B: What situation is this indication most commonly seen

A

A: 1. [PostOp Urinary Retention from Atonic bladder]

  1. [Stimulates peristalsis in PostOp ileus]

B: After Operations, post usually have Urinary Retention in non-moving ileus –> Use Bethanechol

127
Q

Oxybutynin MOA

A

Antimuscarinic

128
Q

What target organ does the M1 Receptor work

A

Brain

129
Q

What target organ does the M2 Receptor work

A

Heart

130
Q

What target organ does the M3 Receptor work (6)

A

“M3’s BEGS for Private Lounges”

Bladder / Eyes / GI / Skin / Peripheral Vasculature / Lungs

131
Q

M1 receptor

Effect

A

Memory Function & Congnition

132
Q

M2 receptor

Effect

A

DECREASES HR & atrial contraction

133
Q

Which condition are [AntiCholinergics (such as Atropine)] contraindicated in?

A

GLAUCOMA!

It causes MyDriasis –> DEC outflow of aqueous humor –> worsens [Closed angle Glaucoma]

134
Q

Which Rx is commonly used to treat Bradycardia

A

Atropine (Anticholinergic)

(DEC vagal influence on SA & AV nodes)

135
Q

Which 2 drugs lower intraocular pressure in Glaucoma? How?

A

Carbachol & Pilocarpine

These [Muscarinic Cholinergic agnoist] cause miosis which moves iris further from the cornea and widens [ANT chamber angle] to allow outflow of aqueous humor

136
Q

[Muscarinic Cholinergic agonist] SE (5)

A

[GI: NVD / Abd pain] (INC GI smooth m. tone)

INC Secretions (sweating/lacrimation/salivation)

Dyspnea

Bradycardia

hypOtension